Fujioka T, Teramoto S, Tsujimi S, Takemoto K, Mori T, Hosokawa T, Sumida T, Tominaga M, Yabuuchi Y
2nd Tokushima Institute of New Drug Research, Otsuka Pharmaceutical Co., Ltd., Japan.
Chem Pharm Bull (Tokyo). 1996 Aug;44(8):1596-8. doi: 10.1248/cpb.44.1596.
The enantiomers of 6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolinon e (OPC-18790), a novel cardiotonic agent, were synthesized and evaluated for positive inotropic activity. The key intermediates, 2,3-epoxypropoxy derivatives, were obtained by the alkylation of 6-hydroxy-2(1H)-quinolinone with optically active epichlorohydrin and subsequent ring closure. In an in vitro study, the (R)-(+)-isomer was about 10-fold more potent than the (S)-(-)-isomer.